A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy

A key factor in dendritic cell (DC)-based tumor immunotherapy is the identification of an immunoadjuvant capable of inducing DC maturation to enhance cellular immunity. The efficacy of a 50S ribosomal protein L7/L12 (rplL) from Mycobacterium tuberculosis Rv0652, as an immunoadjuvant for DC-based tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Seung Jun, Shin, Sung Jae, Lee, Moon Hee, Lee, Min-Goo, Kang, Tae Heung, Park, Won Sun, Soh, Byoung Yul, Park, Jung Hee, Shin, Yong Kyoo, Kim, Han Wool, Yun, Cheol-Heui, Jung, In Duk, Park, Yeong-Min
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4125215/
https://ncbi.nlm.nih.gov/pubmed/25102137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0104351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados